niacinamide has been researched along with Infarct of the Spleen in 1 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sorafenib, a multitargeted tyrosine kinase inhibitor, has been shown to improve survival in patients with advanced hepatocellular carcinoma (HCC)." | 7.77 | Splenic infarction associated with sorafenib use in a hepatocellular carcinoma patient. ( Baek, YH; Cho, JH; Han, JS; Han, SY; Kim, BG; Kim, SO; Lee, SW; Nam, KJ, 2011) |
| "Sorafenib, a multitargeted tyrosine kinase inhibitor, has been shown to improve survival in patients with advanced hepatocellular carcinoma (HCC)." | 3.77 | Splenic infarction associated with sorafenib use in a hepatocellular carcinoma patient. ( Baek, YH; Cho, JH; Han, JS; Han, SY; Kim, BG; Kim, SO; Lee, SW; Nam, KJ, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, SO | 1 |
| Han, SY | 1 |
| Baek, YH | 1 |
| Lee, SW | 1 |
| Han, JS | 1 |
| Kim, BG | 1 |
| Cho, JH | 1 |
| Nam, KJ | 1 |
1 other study available for niacinamide and Infarct of the Spleen
| Article | Year |
|---|---|
Splenic infarction associated with sorafenib use in a hepatocellular carcinoma patient.
Topics: Aged; Antineoplastic Agents; Aspirin; Benzenesulfonates; Carcinoma, Hepatocellular; Contrast Media; | 2011 |